JOURNEY1, Inc.
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
7
Ending by 2030
Apr 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jul 26, 2027The maintenance fee for Conformable therapeutic shield for vision and pain (US 9,241,837) comes due Jul 26, 2027. Unpaid by Jan 26, 2028, it lapses early.
- 1 fee due Aug 11, 2027The maintenance fee for Therapeutic device for pain management and vision (US 10,555,804) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
- 1 fee due Sep 24, 2027The maintenance fee for Corneal denervation for treatment of ocular pain (US 10,596,038) comes due Sep 24, 2027. Unpaid by Mar 24, 2028, it lapses early.
- 1 fee due Oct 21, 2027The maintenance fee for Conformable therapeutic shield for vision and pain (US 10,627,649) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,555,804 | Therapeutic device for pain management and vision In force · From the USPTO record | In force | From the USPTO record | |
| US 8,459,793 | Conformable therapeutic shield for vision and pain In force · From the USPTO record | In force | From the USPTO record | |
| US 9,241,837 | Conformable therapeutic shield for vision and pain In force · From the USPTO record | In force | From the USPTO record | |
| US 9,423,632 | Contact Lenses for Refractive Correction In force · High confidence | In force | High confidence | |
| US 9,465,233 | Bimodular Contact Lenses In force · High confidence | In force | High confidence | |
| US 9,810,921 | Conformable therapeutic shield for vision and pain In force · From the USPTO record | In force | From the USPTO record | |
| US 10,663,761 | Conformable therapeutic shield for vision and pain In force · From the USPTO record | In force | From the USPTO record | |
| US 10,596,038 | Corneal denervation for treatment of ocular pain In force · From the USPTO record | In force | From the USPTO record | |
| US 9,395,558 | Methods and apparatus to identify eye coverings for vision In force · From the USPTO record | In force | From the USPTO record | |
| US 10,627,649 | Conformable therapeutic shield for vision and pain In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 22: 2 patents in force now held by others · 6 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 1 no status recorded